RHESOU (Registre de l’Hérault spécialisé en onco-urologie) : le premier registre français spécialisé en onco-urologie. Un outil méthodologique de recueil de données en onco-urologie. Bilan de faisabilité sur un an d’expérience
| Autor: | Trouche-sabatier, S.G., Rebillard, X., Iborra, F., Azria, D., Daures, J.-P., Poinas, G., Abdo, N., Delbos, O., Gevorgyan, A., Marchal, S., Guillon, R., Millet, I., Lamy, P.-J., Lauche, O., Reis-Borges, R., Serre, I., Topart, D., Tretarre, B. |
|---|---|
| Přispěvatelé: | Registre des Tumeurs de l'Hérault, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Clinique Beau Soleil [Montpellier], Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Urodoc [Montpellier], Polyclinique Saint Privat, Institut Montpelliérain Alexander Grothendieck (IMAG), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Institut médical d'anayse génomique (IMAGENOME), Labosud, Clinique Clémentville [Montpellier], Inopath Labosud Alco [Montpellier] |
| Jazyk: | francouzština |
| Rok vydání: | 2020 |
| Předmět: |
Male
Registry Urologic Neoplasms MESH: Registries Epidemiology Medical Oncology [SDV.MHEP.UN]Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology Male genital cancers Male and female urological cancers Humans Cancers génitaux masculins Registries MESH: Medical Oncology MESH: Humans MESH: Urologic Neoplasms Prostatic Neoplasms MESH: Male Kidney Neoplasms MESH: Urinary Bladder Neoplasms Épidémiologie MESH: France Cancers urologiques Urinary Bladder Neoplasms Registre MESH: Prostatic Neoplasms Base de données Cancers urologiques féminins Data collection Female France MESH: Kidney Neoplasms MESH: Female |
| Zdroj: | Progrès en Urologie Progrès en Urologie, Elsevier Masson, 2020, 30 (16), pp.1038-1044. ⟨10.1016/j.purol.2020.09.015⟩ |
| ISSN: | 1166-7087 |
| DOI: | 10.1016/j.purol.2020.09.015⟩ |
| Popis: | International audience; Purpose: In 2016, the Herault tumor registry collected 1961cancers in urology (21.4 % from all Herault cancers this year). RHESOU was created to complete RTH' data with specific parameters in onco-urology. The aim of this study is to describe RHESOU and to give some examples with our first results.Material and methods: In November 2018, RHESOU (Registry HErault Specialised in Onco-Urology) was founded with the same registry recommendations. It collects specific oncologic parameters and also complete RTH's data. For each urological cancer, a specific survey with different choices was performed to collect a maximum of data which could be present in patients' file. These surveys were used for urological cancers cases that live in Herault in 2017.Results: In 2017, we collected 970 prostate cancers, 581 bladder cancers, 212 kidney cancers, 51 upper excretory tract cancers, 28 testicle cancers and 9 penil cancers. Our urological data collection gives many possibilities to create many requests for detailed analysis in urological cancers. In this article, we reported data from kidney, bladder and prostate cancers.Conclusions: RHESOU is a new tool opened to the different urologic corporations (urologists, pathologists, oncologists, radiotherapists, radiologists) that permits an overview in urological cancers in Herault. Finally, one important aim is that this tool will be adapted when new treatments or new important parameters appear in the years ahead.Level of evidence: 3. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|